Ozempic stock price is benefitting from rotational flows

Ozempic stock price is benefitting from rotational flows into defensive healthcare plays amid broader market volatility. Shares at $124.70 are drawing interest from dividend-growth investors eyeing sustained cash flow from flagship products. Stanley cited the lack of momentum in US prescriptions as the reason for its cautious outlook on the firm’s short-term growth profile, which led to the downgrade. Ozempic Maker’s Stock Plunges 20% After Profit Warning Ozempic stock price is in focus as hedge funds increase exposure, betting on continued growth in the GLP-1 treatment category. Shares remained above the psychological $124 mark, with sentiment buoyed by cross-market demand from Europe and the U.S.